ONCOPOOL -a European database for 16,944 cases of breast cancer, Eur J Cancer. janv, vol.46, issue.1, pp.56-71, 2010. ,
Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor???Positive Breast Cancer, Journal of Clinical Oncology, vol.27, issue.17, pp.2809-2815, 2009. ,
DOI : 10.1200/JCO.2008.18.2808
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women, Lancet, vol.339, pp.71-85, 1992. ,
Young age: an independent risk factor for disease-free survival in women with operable breast cancer, BMC Cancer, vol.107, issue.1 ,
DOI : 10.1002/ijc.11460
Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer, British Journal of Cancer, vol.16, issue.2, pp.382-387, 2012. ,
DOI : 10.1016/S1470-2045(09)70262-1
Prognostic and predictive factors in breast cancer by immunohistochemical analysis, Mod Pathol. févr, vol.11, issue.2, pp.155-168, 1998. ,
Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases, Journal of Clinical Oncology, vol.21, issue.10, pp.1973-1979, 2003. ,
DOI : 10.1200/JCO.2003.09.099
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, vol.9, issue.5 ,
DOI : 10.1016/0277-5379(88)90171-X
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12???155 patients, British Journal of Cancer, vol.27, issue.10, pp.1504-1513, 2007. ,
DOI : 10.1002/1097-0142(19910115)67:2<421::AID-CNCR2820670217>3.0.CO;2-Q
MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups, Breast Cancer Research and Treatment, vol.23, issue.7, pp.591-600, 2010. ,
DOI : 10.1007/s10549-010-1028-3
URL : https://hal.archives-ouvertes.fr/hal-00615364
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer, JNCI Journal of the National Cancer Institute, vol.101, issue.10, pp.736-750, 2009. ,
DOI : 10.1093/jnci/djp082
Evaluation of an optimal cut-off point for the Ki-67 index as a prognostic factor in primary breast cancer, 2012. ,
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013, Annals of Oncology, vol.24, issue.9, pp.2206-2223, 2013. ,
DOI : 10.1093/annonc/mdt303
Human breast cancer: correlation of relapse and survival with amplification of the ,
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2, New England Journal of Medicine, vol.344, issue.11, pp.783-792, 2001. ,
DOI : 10.1056/NEJM200103153441101
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor???Positive Breast Cancer, Journal of Clinical Oncology, vol.24, issue.23, pp.3726-3734, 2006. ,
DOI : 10.1200/JCO.2005.04.7985
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor???Positive Tumors, New England Journal of Medicine, vol.320, issue.8, pp.479-84, 1989. ,
DOI : 10.1056/NEJM198902233200802
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer, New England Journal of Medicine, vol.351, issue.27, pp.2817-2843, 2004. ,
DOI : 10.1056/NEJMoa041588
Gene expression profiling predicts clinical outcome of breast cancer, Nature, vol.415, issue.6871, pp.530-536, 2002. ,
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer, New England Journal of Medicine, vol.347, issue.25, pp.1999-2009, 2002. ,
DOI : 10.1056/NEJMoa021967
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer, JNCI Journal of the National Cancer Institute, vol.98, issue.17 ,
DOI : 10.1093/jnci/djj329
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis, JNCI Journal of the National Cancer Institute, vol.98, issue.4, pp.262-272, 2006. ,
DOI : 10.1093/jnci/djj052
Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048, 2000. ,
Lymph node micrometastases from breast carcinoma, Cancer, vol.221, issue.7, pp.1188-97, 1997. ,
DOI : 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO;2-H
Natural history of node-negative breast cancer: are conventional prognostic factors predictors of time to relapse?, The Breast, vol.11, issue.5, pp.442-450, 2002. ,
DOI : 10.1054/brst.2002.0462
Concurrent versus sequential chemohormonal therapy versus tamoxifen alone for postmenopausal, node?positive, ER and/or PgR?positive breast cancer: mature outcomes and new biologic correlates on phase III intergroup trial 0100 (S8814), Breast Cancer Res Treat, vol.90, p.95, 2005. ,
International Web-based consultation on priorities for translational breast cancer research, Breast Cancer Research, vol.59, issue.6, p.81, 2007. ,
DOI : 10.1136/jcp.2005.033043
Repeated observation of breast tumor subtypes in independent gene expression data sets, Proceedings of the National Academy of Sciences, vol.100, issue.14, pp.8418-8423, 2003. ,
DOI : 10.1073/pnas.0932692100
Meta-analysis of the decision impact of the 21-gene breast cancer recurrence score in clinical practice [abstract] Cancer Res, p.210, 2010. ,
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer, Cancer, vol.7, issue.6, pp.1011-1018, 2007. ,
DOI : 10.1002/cncr.22506
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer, Breast Cancer Research and Treatment, vol.4, issue.6, pp.10549-10561 ,
DOI : 10.1007/s10549-012-1989-5
Breast cancer molecular profiling with single sample predictors: a retrospective analysis, The Lancet Oncology, vol.11, issue.4, pp.339-349, 2010. ,
DOI : 10.1016/S1470-2045(10)70008-5